Toxicologist, Principal Scientist
Novo Nordisk
Bagsvaerd, Hovedstaden, Denmark
Nonclinical Program Considerations for Peptide Safety Assessment (S02)
Monday, November 18, 2024
9:00 AM - 12:00 PM CT
Case Studies of Peptide Safety Assessment (S02-4)
Monday, November 18, 2024
10:45 AM - 11:15 AM CT